UNSPSC 51391716: Divabuterol

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BVG9H4U2ZB. European Medicines Agency schedules Divabuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06337MIG. Divabuterol generally arises in the molecular formula C22H35NO5.

UNSPSC 51391716 Divabuterol, a Commodity code, nominally identifies a specific bronchodilator pharmaceutical, but the recent state and local procurement record shows little activity tagged directly to this code. The single concrete opportunity in the recent record—Seminole County, Florida's IFB60459723LAS—procures naloxone and drug deactivation systems, products unrelated to divabuterol's therapeutic scope. A second recent posting from the Texas Health and Human Services Commission (HHS0017013) is an RFI exploring direct-to-manufacturer prescription fulfillment models and does not reference divabuterol or any specific pharmaceutical product. The issuing bodies span county health departments and state health agencies, but the actual work being solicited under this code does not align with divabuterol procurement.

Geographic activity centered on Florida and Texas in the recent record, though both opportunities diverge substantially from the code's nominal pharmaceutical scope. Seminole County's naloxone and drug deactivation systems IFB, posted June 30, 2026, with a response deadline of July 26, 2023, requires 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and includes a two-year initial term with one-year renewal option. The Texas HHS RFI (HHS0017013), posted April 3, 2026, with the same-day response deadline, gathers vendor capabilities on direct-to-manufacturer prescription programs but does not name divabuterol or solicit the pharmaceutical itself. The code shows minimal recent state and local contracting activity aligned with its stated commodity definition, suggesting either low demand for divabuterol procurement through public channels or systematic coding misalignment in the opportunities capture.